MANGOCEUTICALS, INC. (MGRX) Return on equity 2022–2025
MANGOCEUTICALS, INC. (MGRX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-135.8%FY2025 · since FY2022: -325.4% → -135.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -135.8% | -73.4 pp |
| FY2024 | -62.4% | +1126.6 pp |
| FY2023 | -1189.1% | -863.7 pp |
| FY2022 | -325.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice